Background and aim
==================

Nocebo affects significantly adherence and treatment outcome and varies considerably among neurological conditions. We aimed to evaluate a questionnaire to predict nocebo in outpatients seeking neurological consultation.

Methods
=======

A four-item (rating range 0-20) self-fulfilled questionnaire (Q-No) was given in outpatients seeking neurological consultation at the Athens Naval Hospital. A blind to Q-No scoring neurologist rated outpatients as nocebo or no-nocebo after follow-up of \>6 months.

Results
=======

338 (71.6% females) patients with mean age 46.9 (±13.8) years fulfilled the Q-No and the mean total score was 13.2 (±3.7). The Crombach\'s alpha coefficient was 0.627. Neurologist suggested 80 patients (23.7%) as nocebo and 258 as no-nocebo (mean Q-No score=12.4 95% CI: \[12.0-12.9\] and 15.8, 95%CI: \[15.1-16.6\], respectively). By using a cut-off at score 16 the Q-No predicts nocebo with 82.6% specificity and 61.3% sensitivity.

Conclusions
===========

Q-No may serve as a useful tool to predict nocebo in outpatients seeking neurological consultation.
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